Biofrontera Inc. (NASDAQ:BFRIW – Get Free Report) was the recipient of a large decrease in short interest in the month of June. As of June 15th, there was short interest totaling 4,105 shares, a decrease of 38.1% from the May 31st total of 6,628 shares. Based on an average trading volume of 1,397 shares, the short-interest ratio is presently 2.9 days.
Biofrontera Stock Performance
Shares of NASDAQ:BFRIW remained flat at $0.03 during mid-day trading on Thursday. 704 shares of the company were exchanged, compared to its average volume of 6,009. The company has a 50 day simple moving average of $0.03 and a 200-day simple moving average of $0.05. Biofrontera has a 52 week low of $0.02 and a 52 week high of $0.28.
Biofrontera Company Profile
Biofrontera AG is a biopharmaceutical company headquartered in Leverkusen, Germany, specializing in the development, manufacture and commercialization of dermatology products. Founded in 1997, the company focuses on therapies for skin diseases through innovative drug and device combinations. Its core business centers on photodynamic therapy, where a photosensitizing agent is activated by a specialized light source to treat precancerous and cancerous skin conditions.
The company’s flagship product, Ameluz, is a topical formulation of aminolevulinic acid used in conjunction with the BF-RhodoLED irradiation device.
Recommended Stories
- Five stocks we like better than Biofrontera
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
- General Mills Is a 5-Star Turnaround Play for Buy and Hold Investors
- Agility Robotics’ SPAC Deal Opens a Rare Door Into Humanoid AI
Receive News & Ratings for Biofrontera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biofrontera and related companies with MarketBeat.com's FREE daily email newsletter.
